La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Nephros a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Nephros..

Nephros (NASDAQ:NEPH) Azioni, Quote.MetaTitle.option-chain

Nephros

Nephros Inc

Nuburu

ClearSign Technologies Corporation - Common Stock

ClearSign Technologies

Chicago Rivet & Machine

Eastern

Gencor Industries

Greenland Technologies Holding Corporation - Ordinary Shares

Greenland Technologies

Highway Holdings

Hurco Companies

INLIF

JE Cleantech Holdings Limited - Ordinary Shares

JE Cleantech Holdings

Laser Photonics Corporation - Common Stock

Laser Photonics

Li Bang International Corporation Inc. - Ordinary Shares

Li Bang International

LiqTech International, Inc. - Common Stock

LiqTech International

Micropolis Holding Company Ordinary Shares

Micropolis Hldgs

Palladyne AI

Perma-Pipe International Holdings, Inc. - Common Stock

Perma-Pipe Inlt Hldgs

Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock

Rain Enhancement

374Water

Taylor Devices

Techprecision

Velo3D

WF Holding

ZJK Industrial Co., Ltd. - Ordinary Shares

ZJK Industrial

CleanCore Solutions Inc. Class B Common Stock

CleanCore Solutions

Nephros (NEPH) Previsione

Notizie

Utili

Guidance

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Comments

Nephros Catena di Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO